ICON, a global provider of drug development solutions and services has acquired MolecularMD, a molecular diagnostic specialty laboratory that enables the development and commercialization of precision medicines in oncology. The acquisition of MolecularMD’s extensive scientific and clinical biomarker
Read More
The CVS-Aetna merger has the potential to create an integrated model for consumer healthcare that could transform the consumer experience; however, are consumers embracing the prospect of receiving
Read More
Dosis, a San Francisco, CA-based developer of the Strategic Anemia Advisor (SAA) decision support tool, announced today that it has expanded its AI-powered personalized dosing platform to support to
Read More
Covera Health, an NYC-based provider of analytics-based programs to reduce medical misdiagnoses and improve quality of care has raised $8.5 million in Series A funding led by Equity Group Investments
Read More
A frequent knock on electronic health records (EHRs) has been that they’re just glorified billing systems that fail to provide enough clinical functionality to make a significant difference in the quality of care. So it’s somewhat incongruous that a recent Black Book report on revenue cycle management (RCM) system adoption would say that 26 percent of hospitals … Read More
HMS’ Jennifer Forster explains how payers can cut costs and improve population health outcomes by incorporating social determinants of health (SDoH) into the mix. While the future of precision medicine is often associated with advances in genomics, there is more to consider when it comes to developing personalized treatment and PHM efforts. In fact, considering … Read More
